Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis
暂无分享,去创建一个
Claudio Cobelli | Andrea Facchinetti | Chiara Fabris | Giuseppe Fico | Maria Teresa Arredondo | Francesco Sambo | C. Cobelli | A. Facchinetti | G. Fico | M. T. Arredondo | C. Fabris | Francesco Sambo | M. Arredondo
[1] Dan Shen,et al. Consistency of sparse PCA in High Dimension, Low Sample Size contexts , 2011, J. Multivar. Anal..
[2] W. F. Taylor,et al. Mean Amplitude of Glycemic Excursions, a Measure of Diabetic Instability , 1970, Diabetes.
[3] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[4] F. Service,et al. Characteristics of Glycemic Stability , 1980, Diabetes Care.
[5] Wójcicki Jm,et al. J"-index. A new proposition of the assessment of current glucose control in diabetic patients. , 1995 .
[6] R. Tibshirani,et al. Sparse Principal Component Analysis , 2006 .
[7] David Rodbard,et al. Clinical Interpretation of Indices of Quality of Glycemic Control and Glycemic Variability , 2011, Postgraduate medicine.
[8] Peter A Baghurst,et al. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. , 2011, Diabetes technology & therapeutics.
[9] Razvan C. Bunescu,et al. A Consensus Perceived Glycemic Variability Metric , 2013, Journal of diabetes science and technology.
[10] David Rodbard,et al. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. , 2009, Diabetes technology & therapeutics.
[11] Howard Zisser,et al. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.
[12] J. Škrha,et al. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control. , 2014, Diabetes technology & therapeutics.
[13] Giovanni Sparacino,et al. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis. , 2014, Diabetes technology & therapeutics.
[14] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[15] J. Marron,et al. PCA CONSISTENCY IN HIGH DIMENSION, LOW SAMPLE SIZE CONTEXT , 2009, 0911.3827.
[16] David Rodbard,et al. Glycemic variability: measurement and utility in clinical medicine and research--one viewpoint. , 2011, Diabetes technology & therapeutics.
[17] Ian T. Jolliffe,et al. Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.
[18] Michael Brownlee,et al. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.
[19] David Rodbard,et al. New and improved methods to characterize glycemic variability using continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.
[20] Boris Kovatchev,et al. Statistical tools to analyze continuous glucose monitor data. , 2009, Diabetes technology & therapeutics.
[21] A. Shapiro,et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. , 2004, Diabetes.
[22] Giovanni Sparacino,et al. A dynamic risk measure from continuous glucose monitoring data. , 2011, Diabetes technology & therapeutics.
[23] C. McDonnell,et al. A novel approach to continuous glucose analysis utilizing glycemic variation. , 2005, Diabetes technology & therapeutics.
[24] D. Cox,et al. Symmetrization of the Blood Glucose Measurement Scale and Its Applications , 1997, Diabetes Care.
[25] Jean-Paul Cristol,et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.
[26] I. Hirsch,et al. Should minimal blood glucose variability become the gold standard of glycemic control? , 2005, Journal of diabetes and its complications.
[27] J. S. Marron,et al. Boundary behavior in High Dimension, Low Sample Size asymptotics of PCA , 2012, J. Multivar. Anal..
[28] Irl B Hirsch,et al. Glycemic variability: it's not just about A1C anymore! , 2005, Diabetes technology & therapeutics.
[29] J. Schlichtkrull,et al. THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS. , 1965, Acta medica Scandinavica.
[30] J. Levy,et al. A method for assessing quality of control from glucose profiles , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[31] Martin Straume,et al. Risk Analysis of Blood Glucose Data: A Quantitative Approach to Optimizing the Control of Insulin Dependent Diabetes , 2000 .